Adicet Bio’s (ACET) “Buy” Rating Reiterated at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Adicet Bio (NASDAQ:ACET – Free Report) in a research report sent to investors on Monday, Benzinga reports. The brokerage currently has a $10.00 target price on the stock. Several other equities analysts have also issued reports on the company. Wedbush reaffirmed an outperform rating and set […]

Leave a Reply

Your email address will not be published.

Previous post Baltic Classifieds Group (LON:BCG) Earns Buy Rating from Analysts at Berenberg Bank
Next post Stock Traders Purchase Large Volume of Call Options on uniQure (NASDAQ:QURE)